Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non Operating Income (2016 - 2022)

Neurocrine Biosciences (NBIX) has disclosed Other Non Operating Income for 10 consecutive years, with -$18.4 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Other Non Operating Income changed N/A year-over-year to -$18.4 million, compared with a TTM value of -$18.2 million through Jun 2023, changed N/A, and an annual FY2020 reading of -$18.4 million, changed N/A over the prior year.
  • Other Non Operating Income was -$18.4 million for Q4 2020 at Neurocrine Biosciences, down from $183000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $879000.0 in Q1 2017 and bottomed at -$18.4 million in Q4 2020.
  • Average Other Non Operating Income over 4 years is -$1.4 million, with a median of $201000.0 recorded in 2018.
  • The sharpest move saw Other Non Operating Income skyrocketed 107.21% in 2017, then crashed 79.18% in 2018.
  • Year by year, Other Non Operating Income stood at -$2.5 million in 2016, then surged by 107.21% to $183000.0 in 2017, then changed by 0.0% to $183000.0 in 2018, then crashed by 10154.64% to -$18.4 million in 2020.
  • Business Quant data shows Other Non Operating Income for NBIX at -$18.4 million in Q4 2020, $183000.0 in Q2 2018, and $201000.0 in Q1 2018.